COHANCE logo

Cohance Lifesciences LTD

COHANCE·NSE·
460.85 +4.90 (+1.07%)
Market Cap17615.38 Cr
PE Ratio98.47
Volume21,35,807
Day High - Low476.50 - 455.00
52W High-Low1038.90 - 266.70
DocStoX Score
3.6/10
Poor
Fair Value
Sign in to see
ROE
7.04%
Weak
P/E
98.47x
Expensive
Debt / Equity
0.03
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day455.00
476.50
52W266.70
1039
DocStoX take

Supported by risk (8.7), but held back by valuation (0.0). Risk looks strong at 8.7, but that is offset by valuation at 0.0 and momentum at 1.4 and growth at 2.8. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
3.6
/10
Poor
Quality
Modest
ROE 7.0%
Valuation
Expensive
P/E 98.5×
Growth
Flat
Revenue +17.6% 5Y CAGR
Risk
Low risk
D/E 0.03
Momentum
Weak
25% of 52-week range

At a glance

Market Cap
₹17,615 Cr
52W High / Low
₹1039 / ₹267
Dividend Yield
1.32%
Promoter Holding
57.49%
EPS (TTM)
₹4.68
Book Value
₹102.00

Key highlights

  • Low leverage — D/E 0.03
  • Profitable in all of the last 5 years
  • Revenue compounding 18% a year
  • Profit shrinking 16% a year
  • Valuation is weak (0.0/10)
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

COHANCE LIFESCIENCES LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.